Abdulatif M, Mowafi H, al-Ghamdi A, el-Sanabary M
Department of Anaesthesia, Cairo University, Egypt.
Br J Anaesth. 1996 Dec;77(6):710-5. doi: 10.1093/bja/77.6.710.
Dose-response relationships for the antagonism of intermediate-acting neuromuscular blocking agents have not been evaluated previously in children. We have examined the dose-response relationships for neostigmine antagonism of 90% rocuronium-induced neuromuscular block in children and adults, during nitrous oxide-1 MAC of isoflurane anaesthesia. We studied 40 children, aged 2-10 yr, and 50 adults, aged 18-60 yr; all received a single bolus dose of rocuronium 0.6 mg kg-1 and accelerometry was used to monitor neuromuscular transmission. When the first twitch of the train-of-four (TOF) response (T1) recovered to 10% of its control (T0), one of five doses of neostigmine 0, 5, 10, 20 or 50 micrograms kg-1 was given by random allocation to each of the study groups (n = 8 children and n = 10 adults). Recovery of T1 and TOF ratio (T4/T1%) was recorded for 10 min after initial administration of neostigmine. Onset time of rocuronium-induced block was faster in children than in adults (mean 64.6 (95% confidence intervals 57.7-71.5) s vs 83.7 (70.7-96.6) s; P < 0.05). The time to 10% recovery of T1/T0 was shorter in children than in adults (25.4 (22.9-27.9) min vs 38.8 (36.1-41.4) min; P < 0.001). Spontaneous and antagonist-assisted recovery were more rapid in children than in adults. Adequate recovery (T4/T1 of 80%) occurred in children at 4, 5 and 8 min after neostigmine 50, 20 and 10 micrograms kg-1, respectively. Adequate recovery was not produced in adults by any dose of neostigmine within 10 min. The effective doses of neostigmine required to achieve a TOF ratio of 80% (ED80) after 10 min in children and adults were, respectively, 7.10 (5.2-9.8) micrograms kg-1 and 56.56 (45.5-71.9) micrograms kg-1 (P < 0.001). There was no advantage in administering doses of neostigmine greater than 20 micrograms kg-1 to antagonize 90% rocuronium-induced neuromuscular block in children. In contrast, it appeared prudent to use neostigmine 50 micrograms kg-1 or more for adequate antagonism of a similar degree of block in adults.
此前尚未评估过儿童对中效神经肌肉阻滞剂拮抗作用的剂量-反应关系。我们研究了在氧化亚氮-1 MAC异氟烷麻醉期间,新斯的明拮抗90%罗库溴铵诱导的儿童和成人神经肌肉阻滞的剂量-反应关系。我们研究了40名2至10岁的儿童和50名18至60岁的成人;所有人均接受单次静脉推注剂量的罗库溴铵0.6 mg/kg,并使用加速度计监测神经肌肉传递。当四个成串刺激(TOF)反应的第一个颤搐(T1)恢复至其对照值(T0)的10%时,通过随机分配,向每个研究组(n = 8名儿童和n = 10名成人)给予五剂新斯的明(0、5、10、20或50 μg/kg)中的一剂。在首次给予新斯的明后记录10分钟内T1和TOF比值(T4/T1%)的恢复情况。罗库溴铵诱导阻滞的起效时间在儿童中比成人更快(平均64.6(95%置信区间57.7 - 71.5)秒对83.7(70.7 - 96.6)秒;P < 0.05)。T1/T0恢复至10%的时间在儿童中比成人短(25.4(22.9 - 27.9)分钟对38.8(36.1 - 41.4)分钟;P < 0.001)。儿童的自发恢复和拮抗剂辅助恢复比成人更快。分别在给予新斯的明50、20和10 μg/kg后4、5和8分钟,儿童出现充分恢复(T4/T1为80%)。在10分钟内,任何剂量的新斯的明均未使成人实现充分恢复。儿童和成人在10分钟后达到TOF比值80%(ED80)所需的新斯的明有效剂量分别为7.10(5.2 - 9.8)μg/kg和56.56(45.5 - 71.9)μg/kg(P < 0.001)。对于拮抗90%罗库溴铵诱导的儿童神经肌肉阻滞,给予大于20 μg/kg的新斯的明剂量并无优势。相比之下,对于拮抗成人类似程度的阻滞,使用50 μg/kg或更高剂量的新斯的明似乎更为谨慎。